Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Adalimumab Produkte

(Adalimumab)

Kategorien

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Empfohlene Adalimumab Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation
Validierungen
Kat. Nr. ABIN7482167
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Human
Applikation
Validierungen
Kat. Nr. ABIN7482166
Menge 200 μg
Datenblatt Datenblatt

Empfohlene Adalimumab ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Chemical, Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
  • (1)
Kat. Nr. ABIN2862650
Menge 96 tests
Datenblatt Datenblatt
Reaktivität Human, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validierungen
Kat. Nr. ABIN4886389
Menge 96 tests
Datenblatt Datenblatt

Neueste Publikationen zu unseren Adalimumab Produkten

Sugita, Watanabe, Kamata, Yukawa, Otani, Hosomi, Nagami, Tanaka, Taira, Yamagami, Tanigawa, Shiba, Watanabe, Tominaga, Kabata, Shintani, Arakawa, Fujiwara: "Efficacy of a concomitant elemental diet to reduce the loss of response to adalimumab in patients with intractable Crohn's disease." in: Journal of gastroenterology and hepatology, Vol. 33, Issue 3, pp. 631-637, (2018) (PubMed).

Piñero, Juanola, Gutiérrez, Zapater, Giménez, Steinert, Sempere, González-Navajas, Niess, Francés: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).

Ward, Thwaites, Beswick, Hogg, Rosella, Van Langenberg, Reynolds, Gibson, Sparrow: "Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease." in: Alimentary pharmacology & therapeutics, Vol. 45, Issue 8, pp. 1135-1145, (2017) (PubMed).

Gibellini, De Biasi, Bianchini, Bartolomeo, Fabiano, Manfredini, Ferrari, Albertini, Trenti, Nasi, Pinti, Iannone, Salvarani, Cossarizza, Pellacani: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).

Song, Kang, Choi, Choe: "Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study." in: Pediatric gastroenterology, hepatology & nutrition, Vol. 19, Issue 2, pp. 116-22, (2016) (PubMed).

Bortlik, Duricova, Machkova, Hruba, Lukas, Mitrova, Romanko, Bina, Malickova, Kolar, Lukas: "Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation." in: Scandinavian journal of gastroenterology, Vol. 51, Issue 2, pp. 196-202, (2016) (PubMed).

Bodini, Giannini, Savarino, Savarino: "Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: a useful cutoff in clinical practice." in: The American journal of gastroenterology, Vol. 110, Issue 3, pp. 472-3, (2015) (PubMed).

Juanola, Moratalla, Gutiérrez, Sempere, Zapater, Giménez, Almenta, Peiró, González-Navajas, Such, Francés: "Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease." in: Journal of gastroenterology, Vol. 50, Issue 7, pp. 758-68, (2015) (PubMed).

Gutiérrez, Scharl, Sempere, Holler, Zapater, Almenta, González-Navajas, Such, Wiest, Rogler, Francés: "Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease." in: Gut, Vol. 63, Issue 2, pp. 272-80, (2014) (PubMed).

Bortlik, Duricova, Machkova, Kozeluhova, Kohout, Hrdlicka, Durilova, Mitrova, Hradsky, Bronsky, Malickova, Lukas: "Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children." in: Inflammatory bowel diseases, Vol. 20, Issue 3, pp. 495-501, (2014) (PubMed).

Sie sind hier:
Kundenservice